FMS News and Press, Fresenius Medical Care AG From 05/12/22

With steady revenues and a predictable earnings profile, DaVita is a perfect example of a stock which could add stability to investors' portfolios during periods of volatility. While the company has a hefty debt load, the company's maturity schedule and cash flow offer management a lo...

The markets are in turmoil, crashing at rates that have shocked even market veterans. Half of the Nasdaq is down 50+% and over 20% is down 75+%. Even some dividend aristocrats have fallen 30% to 40% in 2022. This creates bargain-hunting opportunities in 10 aristocrat strong buys: ...

The war in Ukraine continues to dominate market movements. I have started exiting one of my apartment REITs and predominantly focus on adding dividend income via select purchases. The combination of soaring inflation and geopolitical uncertainty has rattled markets and following t...

Fresenius Medical Care AG & Co. (FMS) Q1 2022 Earnings Conference Call May 04, 2022 09:30 AM ET Company Participants Dominik Heger - Head of IR Rice Powell - CEO Helen Giza - CFO Conference Call Participants Patrick Wood - Bank of America Oliver Metzger - ODDO BHF Tom Jones - Berenberg Gr...

Fresenius Medical Care (NYSE:FMS): Q1 Non-GAAP EPS of €0.68. Revenue of €4.55B (+8.1% Y/Y). The Company expects revenue and net income to grow at low to mid-single digit percentage rates in FY 2022 For further details see: Fresenius Medical Care Non-GAAP EPS of &...

Fresenius is an interesting investment - certainly in part because it doesn't require an ADR, you can invest in the medical care wing with the symbol FMS. The company's organic growth has been slowed down, and the recovery for the company is likely in the future - but the upside is no...

Fresenius is a diversified healthcare company. The company pays out a growing dividend. A potential break-up and the reduced effect of Covid could act as tailwinds for the company. For further details see: Fresenius: Undervalued Healthcare Giant

Fresenius Medical Care Launches My Reason® Campaign to Enroll Patients in Groundbreaking Renal-focused Genomic Registry PR Newswire Goal of 100,000 Participants Within Five Years to Help Scientists Better Understand Genetic Variations in Patients with Chronic Kidn...

The war in Ukraine continues to dominate market movements. I am not selling anything and predominantly focus on adding dividend income via select purchases. The combination of soaring inflation and geopolitical uncertainty has rattled markets but despite some dramatic movements, s...

Fresenius Medical Care Appoints Dr. Amaka Eneanya as Head of Strategy and Operations for Company's Global Medical Office PR Newswire WALTHAM, Mass. , April 5, 2022 /PRNewswire/ -- Fresenius Medical Care , the world's leading provider of products and s...